<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/93F98EBB-CCB6-4CA2-839D-647D79208AB3"><gtr:id>93F98EBB-CCB6-4CA2-839D-647D79208AB3</gtr:id><gtr:name>Uganda Virus Research Institute</gtr:name><gtr:address><gtr:line1>PO Box 49</gtr:line1><gtr:line2>Plot 51-59 Nakiwogo road</gtr:line2><gtr:region>outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/ACCAA472-353D-4CD6-814A-04677AE5E921"><gtr:id>ACCAA472-353D-4CD6-814A-04677AE5E921</gtr:id><gtr:name>MRC/UVRI Uganda Research Unit on AIDS</gtr:name><gtr:address><gtr:line1>Uganda Virus Research Institute</gtr:line1><gtr:line2>51-59 Nakiwogo Road, PO box 49</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ACCAA472-353D-4CD6-814A-04677AE5E921"><gtr:id>ACCAA472-353D-4CD6-814A-04677AE5E921</gtr:id><gtr:name>MRC/UVRI Uganda Research Unit on AIDS</gtr:name><gtr:address><gtr:line1>Uganda Virus Research Institute</gtr:line1><gtr:line2>51-59 Nakiwogo Road, PO box 49</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/93F98EBB-CCB6-4CA2-839D-647D79208AB3"><gtr:id>93F98EBB-CCB6-4CA2-839D-647D79208AB3</gtr:id><gtr:name>Uganda Virus Research Institute</gtr:name><gtr:address><gtr:line1>PO Box 49</gtr:line1><gtr:line2>Plot 51-59 Nakiwogo road</gtr:line2><gtr:region>outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CB18B11D-5FF0-498E-8676-369C54B769BF"><gtr:id>CB18B11D-5FF0-498E-8676-369C54B769BF</gtr:id><gtr:firstName>Emma</gtr:firstName><gtr:surname>Thomson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/44F84640-B2B8-4B1D-93E8-88ABCB350198"><gtr:id>44F84640-B2B8-4B1D-93E8-88ABCB350198</gtr:id><gtr:firstName>Edward</gtr:firstName><gtr:surname>Katongole Mbidde</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B5C2A8F2-DAD6-4AEE-BDAC-381A0037E9C5"><gtr:id>B5C2A8F2-DAD6-4AEE-BDAC-381A0037E9C5</gtr:id><gtr:firstName>Pontiano</gtr:firstName><gtr:surname>Kaleebu</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8887F400-FAB8-41AF-BB38-5032ABFF3AD6"><gtr:id>8887F400-FAB8-41AF-BB38-5032ABFF3AD6</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:surname>Newton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15099"><gtr:id>465610BD-3EF4-4FFF-8352-1D82DDB8F868</gtr:id><gtr:title>Zika: Is the Ugandan Population Vulnerable to a Zika Virus Epidemic?</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15099</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>This pilot study will address the question, whether Uganda is vulnerable to a Zika virus
(ZIKV) epidemic. Since its discovery in 1947, no evidence of endemic/epidemic ZIKV
infection has been found in Uganda. However, a virulent, pathogenic ZIKV lineage has
emerged in Asia, quickly spreading to other continents. The emergence of this lineage raises
the question, whether ZIKV strains from Uganda are non-pathogenic or if Ugandans have
built immunity over time or through cross-reactivity to related viral species.
Our aims are 1) to search for ZIKV among mosquitoes and key human cohorts and 2) to
molecularly and phylogenetically characterize Ugandan strains.
To this end, a large mosquito collection representing a broad geographical distribution with
seasonal variation will be screened for ZIKV RNA by RT-PCR and full ZIKV genomes
molecularly characterized using metagenomics next generation sequencing on the MiSeq
platform.
ZIKV sequences derived from mosquitoes will be phylogenetically compared to estimate
evolutionary radiation and divergence from the 1947 strain.
Similarly, stored samples from key human populations (Measles/Rubella Surveillance and
Acute Febrile Illness cohorts, and AIDS Indicator Surveys) will be screened for ZIKV RNA.
Plasma ZIKV sequences will be phylogenetically compared to local mosquitoes sequences and
African/Asian lineages (GenBank). Clinical specimens will also be screened serologically for
evidence of past exposure to ZIKV, already in use at UVRI.
The data generated through this study will form the foundation for further studies to evaluate
Ugandan ZIKV as a prototype target for the development of ZIKV-specific diagnostic assays
and the development of a vaccine using a non-pathogenic live/attenuated strain of the virus.</gtr:technicalSummary><gtr:fund><gtr:end>2017-10-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-03-31</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>88174</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Uganda Virus Research Institute</gtr:collaboratingOrganisation><gtr:country>Uganda, Republic of</gtr:country><gtr:department>Department of Arbovirology, Emerging and Re-emerging Infections</gtr:department><gtr:description>Partnership with UVRI on Zika virus studies</gtr:description><gtr:id>4C820C0D-4A5B-43C6-9BC9-1D9861353FAC</gtr:id><gtr:impact>We have analysed a number of samples, this has let to more collaboration with other partners such as USA CDC and University of Glasgow.</gtr:impact><gtr:outcomeId>58cd2423da69c9.74747232-1</gtr:outcomeId><gtr:partnerContribution>UVRI provides mosquito and human specimens to analyse</gtr:partnerContribution><gtr:piContribution>We provide sequencing expertise and its analyses</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Metagenomics analyses</gtr:description><gtr:id>1BAE1C58-1AE5-4CCF-8977-44373EAC5861</gtr:id><gtr:impact>A new virus has been identified under this arrangements</gtr:impact><gtr:outcomeId>58cd251fc77e91.53035958-1</gtr:outcomeId><gtr:partnerContribution>They have trained our staff in metagenomics</gtr:partnerContribution><gtr:piContribution>We have provides specimens and collaborative research projects</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC-Zika virus funding</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F67B9ECA-34D6-4EE0-B268-111B32739C0F</gtr:id><gtr:outcomeId>58cd2c0e6d5885.58540827</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15099</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>FB395309-E202-4FE8-87B0-041A3D72D4D4</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.5  Research design and methodologies (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes><gtr:rcukProgramme><gtr:id>C11BDEA9-7D9D-4728-B6A9-31032921B328</gtr:id><gtr:text>Newton</gtr:text></gtr:rcukProgramme></gtr:rcukProgrammes></gtr:project></gtr:projectComposition></gtr:projectOverview>